Alpine Immune Sciences
在场
是其中之一......
Alpine Immune Sciences 是一家在股票代码 ALPN (US) 下上市的公司。
涉及Alpine Immune Sciences的并购和融资。
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (公布2024四月16号).
高管
查看带有其 15 名主要高管的组织结构图
Alpine Immune Sciences 搜索最多的简介
- Mitchell Gold, Executive Chairman of the Board and Chief Executive...
- James Topper, Director
- Robert Conway, Director
高管在Alpine Immune Sciences变化
- Wolfgang Dummer已作为Chief Medical Officer加入公司 (新闻发布的2023十月5号).
- Christina Yi已作为Chief Technology Officer加入公司 (新闻发布的2023八月23号).
创建提醒
跟踪 Alpine Immune Sciences 的高管变动
生物技术
Alpine Immune Sciences 拥有 2,281 家竞争者，其中包括 Lonza (瑞士)、Eurofins (卢森堡) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Endeavor BioMedicines 刚刚宣布为 132 筹款数百万美元。 (公布2024四月25号).
- Metsera 刚刚宣布为 290 筹款数百万美元。 (公布2024四月23号).
- Histogen has filed for bankruptcy protection (公布2024四月19号).
生物技术 行业的其他推荐联系人
消息
Alpine Immune Sciences 的最新新闻稿
- Alpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis Congress | Alpine Immune Sciences
- Alpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology Annual Meeting | Alpine Immune Sciences
- Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial Results | Alpine Immune Sciences
- Alpine Immune Sciences Presents New ALPN-101 Preclinical Data at the 2019 American College of Rheumatology (ACR) Annual Meeting | Alpine Immune Sciences
- Alpine Immune Sciences Presents New Preclinical Data at The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting | Alpine Immune Sciences
- Alpine Immune Sciences Announces Oral Presentation of ALPN-101 at the 61st American Society of Hematology Annual Meeting and Exposition | Alpine Immune Sciences
- Alpine Immune Sciences to Present at Upcoming Investor Conferences | Alpine Immune Sciences
- Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products | Alpine Immune Sciences
- Alpine Immune Sciences Completes Enrollment of Phase I Study of ALPN-101 and Announces Third Quarter Conference Call | Alpine Immune Sciences
- Alpine Immune Sciences to Present at 2019 Wedbush PacGrow Healthcare Conference | Alpine Immune Sciences
- View more press releases Close
通过电子邮件
